Table 2.
Cystic Fibrosis | ||||
---|---|---|---|---|
Healthy | All | Heterozygous ΔF508 | Homozygous ΔF508 | |
FVC (L) | 4.6±0.9 | 4.0±1.2 | 3.6±1.4 | 4.2±1.0 |
FVC (% predicted) | 100±9 | 96±30 | 77±21 | 106±30 |
FEV1 (L) | 3.8±0.9 | 2.9±1.1* | 2.7±1.3 | 3.1±1.0 |
FEV1 (% predicted) | 99±12 | 83±28 | 68±26 | 91±26 |
FEV1/FVC (%) | 84±4 | 73±10 * | 72±10 | 74±10 |
FEF25–75 (L/s) | 4.0±1.2 | 2.4±1.4 * | 2.1±1.3 | 2.5±1.5 |
FEF25–75 (% predicted) | 96±26 | 60±30 * | 51±28 | 65±32 |
FVC=forced vital capacity; FEV1=forced expiratory volume after one second of FVC; FEF25–75= forced expiratory flow at 25-75% of FVC. Predicted values for all pulmonary function measures were based on predicted equations from NHANES III. Data presented are mean±SD
p<0.025 vs. healthy. Statistics not performed on ΔF508 groups.